Rakovina Therapeutics Inc. a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday commented on the announcement of a $500 billion private-sector investment into
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has extended its 13-year relationship with Tigermed, a leading
At Arab Health 2025, Myant will showcase its mission to enable human-centric, precise, and preventive care through continuous connection, a vision brought to life by groundbreaking innovations
VSee Health, a leader in comprehensive digital health services and customized telehealth workflow streams, announces contracts with several medical technology solution companies totaling approximately $935,000.
Female healthcare employees, the very professionals tasked with improving women’s health, face significant barriers to accessing and navigating care in the workplace. The Healthcare Businesswomen’s
3LS Ventures Inc., a leading early-stage investor specializing in behavioral health solutions, is proud to announce its strategic investment in Xuron, an innovative healthcare technology company
Canary Technologies, the industry’s leading Guest Management System, today announced the release of its groundbreaking research report on AI trends in the hospitality industry, titled Navigating
Vim, a leader in connected healthcare technology and clinical workflow integration, announced the launch of Care Insights, a transformative solution that embeds actionable, patient-specific data
ObvioHealth, a global leader in digital clinical trial solutions, announced the release of ObvioGo 2.2, the latest version of its innovative platform. This release introduces
TransMedics Group, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, addressed what we believe
WindRose Health Investors, LLC, the New York-based healthcare private equity firm, announced that it has completed a strategic investment in CIVIE (“CIVIE” or the “Company”), an
GATC Health is redefining the landscape of Post-Traumatic Stress Disorder (PTSD) treatment and drug discovery through its proprietary Multiomics Advanced Technology™ (MAT) artificial intelligence (AI)
